Circulating IL-17A accumulation reflects effective target blockade with secukinumab in spondyloarthritis
ObjectivesTo investigate the dynamics of IL-17A levels in patients with spondyloarthritis (SpA) treated with secukinumab and to determine the relationship between circulating IL-17A forms and clinical response.MethodsWe analyzed serum IL-17A levels in …